Skip to content
Webe Honey – Lifestyle
Author:
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’s Disease
June 16, 2026
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
May 12, 2026
Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference
May 7, 2026
Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026
May 5, 2026
←
Previous Page
1
2